期刊文献+

粒细胞集落刺激因子及其受体在儿童神经母细胞瘤中的表达研究 被引量:3

Expression of granulocyte colony-stimulating factor and its receptor in childhood neuroblastoma
下载PDF
导出
摘要 目的检测粒细胞集落刺激因子(G-CSF)及其受体(G-CSFR)在儿童神经母细胞瘤中的表达情况。方法收集2009年1月-2011年6月确诊的神经母细胞瘤患儿手术标本25例。应用免疫组织化学法检测肿瘤标本中G-CSF和G-CSFR的表达,分析G-CSF,G-CSFR的表达与患儿年龄、性别及肿瘤临床分期的相关性。结果神经母细胞瘤标本中,G-CSF和G-CSFR阳性表达率分别为68%、72%。其中,G-CSF与G-CSFR均呈阳性者12例(48%),均呈阴性者2例(8%);一致性检验显示,G-CSF与G-CSFR同时检测均为阳性的标本无一致性(Kappa=-0.0456,P=0.8187)。G-CSF阳性与G-CSFR阴性者5例(20%),G-CSF阴性与G-CSFR阳性者6例(24%)。G-CSF和G-CSFR的表达与性别、年龄及临床分期无显著相关性(P>0.05)。结论无论性别、年龄及临床分期,G-CSF和G-CSFR在儿童神经母细胞瘤中均高表达,对于G-CSFR阳性表达的神经母细胞瘤患者,外源性应用G-CSF应慎重考虑其对肿瘤的影响。 Objective To study the expression of granulocyte colony-stimulating factor (G-CSF) and its receptor (G-CSFR) in neuroblastoma of children. Methods Twenty-five specimens of neuroblastoma were collected in our department during 2009.1-2011.6. G-CSF and G-CSFR were determined by immunohistochemistry. The correlation between expressions of G-CSF and G-CSFR and age, gender and clinical stage were analyzed. Results The expression of G-CSF and G-CSFR in neuroblastoma specimens was 68%, 72% respectively. Both G-CSF and G-CSFRwere positive in 12(48%)specimens, and both G-CSF and G-CSFR were negative in 2 cases (8%). But according to test of concordance, the positive expression of G-CSF and G-CSFR had no concordance in neuroblastoma specimens (Kappa=--0.0456, P=0.8187). There were 5 cases (20%) showed positive-G- CSF but negative-G-CSFR, 6 cases(24%) with negative expression of G-CSF but positive-G-CSFR. No statistical correlation was found between the expression of G-CSF or G-CSFR and gender, age and clinical stage (P〉0.05). Conclusions G-CSF and G-CSFR are highly expressed in children neuroblastoma, regardless of age, gender and clinical stage. For the G-CSFR-positive patients, we recommend the use of G-CSF, and its effect on tumor should be carefully observed.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2012年第12期1103-1106,共4页 Medical Journal of Chinese People's Liberation Army
基金 国家自然科学基金(81170556) 重庆市自然科学基金(CSTC2010BB5112)~~
关键词 粒细胞集落刺激因子 神经母细胞瘤 免疫组织化学 granulocyte colony-stimulating factor granulocyte colony-stimulating factor receptor neuroblastoma immunohistochemistry
  • 相关文献

参考文献15

  • 1Jiang D, Schwarz H. Regulation of granulocyte and macrophage populations of murine bone marrow cells by G-CSF and CD137 protein[J]. PLoS ONE, 2010, 5(12): e15565.
  • 2田丁.粒细胞-克隆刺激因子(G-CSF)的临床应用[J].白血病,1999,8(1):3-4. 被引量:9
  • 3Freyer G, Ligneau B, Trillet-Lenoir V. Colony-stimulating factors in the prevention of solid tumors induced by chemotherapy in patients with febrile neutropenia[J]. Int J Antimicrob Agents, 1998, 10(1): 3-9.
  • 4Usuki K, Urabe A, Masaoka T, et al. Efficacy of granulocyte colony-stimulating factor in the treatment of acute myelogenous leukaemia: a multicentre randomized study[J]. BrJ Haematol, 2002, 116(1): 103-112.
  • 5Moore MA. Hematopoietic growth factors in cancer[J]. Cancer, 1990, 65(3 Suppl): 836-844.
  • 6施诚仁,李仲智.小儿外科学[M].北京:人民卫生出版社,2009:116.
  • 7Nicola NA, Metcalf D. Binding of 12Sl-labeled granulocyte colony-stimulating factor to normal routine hemopoietic ceIls[J].J Cell Physiol, 1985, 124(2): 313-321.
  • 8Morales-Arias J, Meyers PA, Bolontrade MF, el al. Expression of granulocyte-colony-stimulating factor and its receptor in human Ewing sarcoma cells and patient tumor specimens[J]. Cancer, 2007, 110(7): 1568-1577.
  • 9Savarese TM, Mitchell K, McQ.uain C, et al. Co-expression of granulocyte colony stimulating factor and its receptor in primary ovarian carcinomas[J]. Cancer Lett, 2001,162( 1): 10S-1 1S.
  • 10杨小冬,刘福坤,许哲,陈彻,吴晓宇,李刚,黎介寿.G-CSF受体及其mRNA在结直肠癌和其附近正常黏膜中的表达[J].解放军医学杂志,2005,30(2):149-152. 被引量:6

二级参考文献21

  • 1Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol, 2007, 25(1):118.
  • 2Norton JD. ID hdix-loop-helix proteins in cell growth, diferentiation and tumorigenesis. J Cell Sci, 2000,113(pt22):3897.
  • 3Sakarai D, Tsuchiga N, Yamayuchi A, et al. Crucial role of inhibitor of DNA binding/differentiation in the vascular endothelial growth factor-induced activation and angiogenic processes of human endothelial cells. Immunol, 2004,173(9) : 5801.
  • 4Lyden D, Young AZ, Zagzag D, et al. Idl and Id3 are required for neurogenesis, angiogenesis and vascularization of turnout xenografts. Nature, 1999, 401(6754):670.
  • 5Felty Q, Porther N. Estrogen-induced redox sensitive Id3 signaling controls the growth of vascular cells. Atherosclerosis, 2008,198(1): 12.
  • 6Jobim FC, Schwartsmann G, Xavier NL, et al. Expression of MMP-9 and VEGF in breast cancer: correlation with other prognostic indicators. Rev Bras Ginecol Obstet, 2008, 30(6):287.
  • 7Hussein MR, Abd-Elwahed SR, Abdulwahed AR. Alterations of estrogen eceptors, progesterone receptors and C-erbB-2 oncogene protein expression in ductal carcinomas of the breast. Cell Biol Int, 2008, 32(6):698.
  • 8Ninci EB,Brandstetter T,Meinhold-Heerlein I et al. G-CSF receptor expression in ovarian cancer. Int J Gynecol Cancer,2000,10(1):19
  • 9Dalton WS. The tumor microenvironment: focus on myeloma. Cancer Treat Rev,2003,29(Suppl 1):11
  • 10Avalos BR,Gasson JC,Hedvat C et al. Human granulocyte colony-stimulating factor: biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines. Blood,1990,75(4):851

共引文献51

同被引文献59

  • 1梁晨,郭世文.全反式维甲酸对NT2细胞系胶质瘤趋向性的影响[J].西安交通大学学报(医学版),2012,33(4):470-473. 被引量:3
  • 2马清君,李伟平,张怀东.亚砷酸、维甲酸联合小剂量化疗治疗骨髓增生异常综合征的临床疗效[J].现代肿瘤医学,2005,13(4):517-518. 被引量:9
  • 3唐锁勤,黄东生,王建文,冯晨,杨光.大剂量化疗造血干细胞移植治疗IV期神经母细胞瘤的长期疗效研究[J].中国当代儿科杂志,2006,8(2):93-96. 被引量:27
  • 4刘燕雄,单振潮,杜勇.全反式维甲酸诱导大鼠肠神经系统发育异常的实验研究[J].宁夏医科大学学报,2012,3(34):234-236.
  • 5Rothenberg AB, Berdon WE, D "Angio GJ, et al. The association between neuroblastoma and opsoelonus-myoclonus syndrome: a historical review [ J]. Pediatr Radio1,2009,39 (7) :723-726.
  • 6边昕,刘中林,王振常,等.儿童神经母细胞瘤颅面骨转移的影像学表现[C].全国第七届头颈影像学进展学术研讨会暨山西省第十三届放射学术年会论文集,2008:95-97.
  • 7Klein A, Schmitt B, Boltshauser E. Long-term outcome of ten children with opsoclonus-myoclonus syndrome [ J ]. Eur J Pediatr, 2007,166(4) :359-363.
  • 8Cohen LE, Gordon JH, Popovsky EY, et al. Late effects in children treated with intensive multimodal therapy for high-risk neuroblastoma: high incidence of endocrine and growth problems.Bone Marrow Transplant. 201449(4):502-508.
  • 9Vogelzang N J, Benowitz SI, Adams S, et al. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinica Oncology.J Clin Oncol. 2012;30(1 ):88-109.
  • 10Gaze MN, Gains JE, Walker C, et al. Optimization of molecular radiotherapy with [1311]-meta Iodobenzylguanidine for high-risk neuroblastoma.Q J Nucl Med Mol Imaging. 2043;57(1):66-78.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部